I

Intra-Cellular Therapies
D

ITCI

85.430
USD
-0.25
(-0.29%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-99
Market Cap
9,027,125,403
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    ALKS
    -0.150
    (-0.53%)
    28.200 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    E
    ESPR
    0.03000
    (1.43%)
    2.13000 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    749.9 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    More
News

Title: Intra/Cellular Therapies

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.